Dr Andrew Davies at ASH 2014: Phase II/III study of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma

At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Andrew Davies (University of Southampton, Southampton, UK) discusses a phase II/III study comparing the efficacy and safety of lenal... Author: EMJ Added: 04/01/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts